Posted Thu, May, 16,2013
Published today in Substance Abuse: Research and Treatment is a new original research article by Ross M. Colquhoun. Read more about this paper below:
Title
Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
Abstract
The usefulness of oral naltrexone has been limited by compliance. Sub-cutaneous implants would seem to offer a solution to this problem and improve long-term outcomes. The aim of the present study was to compare levels of blood serum naltrexone of patients who had received a naltrexone implant after detoxification to a number of dependent variables of interest. These dependent variables included drug use including urine screens of each patient, any adverse response to the implant, subjective evaluation of self-esteem, quality of relationships, and changes in social functioning. Sixty six patients received an implant and were surveyed; urine and blood samples were taken at about 1, 3, and 6 months after implantation. Naltrexone levels were on average above 1 ng/mL at 6 months after insertion and patients showed significant improvements on all dependent variables. The preliminary evidence indicates that implants can improve compliance rates and outcomes.
Click here to learn more about the article, download it and comment
Posted in: Articles Published
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesI had an excellent experience with the professional editorial team at Libertas Academica. The entire process of submitting the review was easy and required little time. Every step was transparent with immediate responses. I'm really satisfied to have published our article with Libertas Academica.
Facebook Google+ Twitter
Pinterest Tumblr YouTube